HuiHe Healthcare

HuiHe Healthcare is a cardiovascular interventional platform company with independent innovation capabilities, offering self-developed, world-leading products in the fields of cardiac intervention, vascular intervention, electrophysiological intervention, and interventional surgical robotics. In the field of cardiac intervention, the tricuspid annuloplasty system K-Clip™, invented by HuiHe Healthcare, has successfully completed its first clinical trial and gained widespread clinical recognition; it has contributed to the publication of several influential papers and industry consensus documents. The system has now entered the confirmatory clinical trial stage and will soon initiate global multi-center clinical trials. Vascular intervention and other interventional products will successively enter the clinical stage. HuiHe Healthcare employs over 250 staff members, including more than 120 R&D personnel and over 10 employees with medical backgrounds. The company owns more than 130 patents, including 2 PCT patents and 3 North American patents. HuiHe Healthcare holds industry-leading advantages in the research, development, and production of vascular delivery systems, the integration of medical technology, large-scale manufacturing, and the global commercialization of its products.